These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26001553)

  • 41. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies.
    Yoch D
    Int J Pharm Compd; 2017; 21(2):95-102. PubMed ID: 28346203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding?
    Allen LV
    Int J Pharm Compd; 2019; 23(2):123-130. PubMed ID: 31085778
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CDC probes new outbreak associated with compounded steroids.
    Kuehn BM
    JAMA; 2013 Jun; 309(24):2541. PubMed ID: 23800915
    [No Abstract]   [Full Text] [Related]  

  • 45. Analytic Methods Used in Quality Control in a Compounding Pharmacy.
    Allen LV
    Int J Pharm Compd; 2017; 21(1):31-37. PubMed ID: 28346196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimated deaths and illnesses averted during fungal meningitis outbreak associated with contaminated steroid injections, United States, 2012-2013.
    Smith RM; Derado G; Wise M; Harris JR; Chiller T; Meltzer MI; Park BJ
    Emerg Infect Dis; 2015 Jun; 21(6):933-40. PubMed ID: 25989264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Leveraging a multidisciplinary oversight committee to ensure USP <797> and <800> compliance at a Veterans Affairs health system.
    Wrzesniewski CE; Park HK
    Am J Health Syst Pharm; 2022 Feb; 79(4):276-282. PubMed ID: 34724546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Compounding for animal patients: contemporary issues.
    Lust E
    J Am Pharm Assoc (2003); 2004; 44(3):375-84; quiz 384-6. PubMed ID: 15191248
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sterile Basics of Compounding: Repackaging, Part 1.
    Allen LV
    Int J Pharm Compd; 2024; 28(4):298-303. PubMed ID: 39094051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding.
    Akers MJ
    Int J Pharm Compd; 2016; 20(4):307-314. PubMed ID: 28333676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does your pharmacy have a compounding isolator?
    LaBella CJ
    Am J Health Syst Pharm; 2007 Apr; 64(8):855-8. PubMed ID: 17420203
    [No Abstract]   [Full Text] [Related]  

  • 53. U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List).
    Int J Pharm Compd; 2016; 20(6):457-458. PubMed ID: 28339383
    [No Abstract]   [Full Text] [Related]  

  • 54. Avastin doesn't blind people, people blind people.
    Gonzalez S; Rosenfeld PJ; Stewart MW; Brown J; Murphy SP
    Am J Ophthalmol; 2012 Feb; 153(2):196-203.e1. PubMed ID: 22264942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Utilization, Cost, and Pricing Scheme of Compounded Medications for Public Health System Patients: The California Workers' Compensation System, 2011-2013.
    Lin TK; Shoair OA; Tran D; Wilson L
    J Manag Care Spec Pharm; 2019 Jul; 25(7):743-751. PubMed ID: 31232208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Instruction on compounded sterile preparations at schools of pharmacy.
    Dana KN; Hertig JB; Scott CR; Briscoe-Dwyer L
    Am J Health Syst Pharm; 2018 Jun; 75(12):847-849. PubMed ID: 29880517
    [No Abstract]   [Full Text] [Related]  

  • 57. Extemporaneous Compounding: Selective Pharmacists with Separate Skill.
    Mohiuddin AK
    Innov Pharm; 2019; 10(4):. PubMed ID: 34007590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Applying Quality by Design Concepts to Pharmacy Compounding.
    Timko RJ
    Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microbiological validation of a robot for the sterile compounding of injectable non-hazardous medications in a hospital environment.
    Sabatini L; Paolucci D; Marinelli F; Pianetti A; Sbaffo M; Bufarini C; Sisti M
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e63-e68. PubMed ID: 32296508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Choosing a Vial Processing Line for Aseptic Compounding: Part 1.
    Noorian S; Vahedi N
    Int J Pharm Compd; 2016; 20(4):283-292. PubMed ID: 28333673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.